BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18536654)

  • 1. Acute myeloid leukemia harboring t(8;21)(q22;q22): a heterogeneous disease with poor outcome in a subset of patients unrelated to secondary cytogenetic aberrations.
    Lin P; Chen L; Luthra R; Konoplev SN; Wang X; Medeiros LJ
    Mod Pathol; 2008 Aug; 21(8):1029-36. PubMed ID: 18536654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fifty-one patients with acute myeloid leukemia and translocation t(8;21)(q22;q22): an additional deletion in 9q is an adverse prognostic factor.
    Schoch C; Haase D; Haferlach T; Gudat H; Büchner T; Freund M; Link H; Lengfelder E; Wandt H; Sauerland MC; Löffler H; Fonatsch C
    Leukemia; 1996 Aug; 10(8):1288-95. PubMed ID: 8709633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy-related acute myeloid leukemia with t(8;21) (q22;q22) shares many features with de novo acute myeloid leukemia with t(8;21)(q22;q22) but does not have a favorable outcome.
    Gustafson SA; Lin P; Chen SS; Chen L; Abruzzo LV; Luthra R; Medeiros LJ; Wang SA
    Am J Clin Pathol; 2009 May; 131(5):647-55. PubMed ID: 19369623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Heterogeneity of acute myeloid leukemia with the translocation t(8;21)(q22;q22)].
    Gritsaev SV; Martynkevich IS; Ziuzgin IS; Kariagina EV; Martynenko LS; Petrova EV; Tsybakova NIu; Ivanova MP; Kostroma II; Tiranova SA; Potikhonova NA; Abdulkadyrov KM
    Ter Arkh; 2014; 86(7):45-52. PubMed ID: 25314777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and prognostic factors of acute myeloid leukemia with t (8; 21) (q22; q22).
    Lai YY; Qiu JY; Jiang B; Lu XJ; Huang XJ; Zhang Y; Liu YR; Shi HL; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):733-40. PubMed ID: 16277833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia.
    Balgobind BV; Hollink IH; Arentsen-Peters ST; Zimmermann M; Harbott J; Beverloo HB; von Bergh AR; Cloos J; Kaspers GJ; de Haas V; Zemanova Z; Stary J; Cayuela JM; Baruchel A; Creutzig U; Reinhardt D; Pieters R; Zwaan CM; van den Heuvel-Eibrink MM
    Haematologica; 2011 Oct; 96(10):1478-87. PubMed ID: 21791472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic analysis of acute myeloid leukemia with t(8;21) from a tertiary care center in India with correlation between clinicopathologic characteristics and molecular analysis.
    Parihar M; Kumar JA; Sitaram U; Balasubramanian P; Abraham A; Viswabandya A; George B; Mathews V; Srivastava A; Srivastava VM
    Leuk Lymphoma; 2012 Jan; 53(1):103-9. PubMed ID: 21745004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexistent t(8;21)(q22;q22) Translocation and 5q Deletion in Acute Myeloid Leukemia.
    Yamamoto K; Yakushijin K; Sanada Y; Kawamoto S; Matsuoka H; Minami H
    J Clin Exp Hematop; 2015; 55(3):181-5. PubMed ID: 26763368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric acute myeloid leukemia with t(7;21)(p22;q22).
    Paulraj P; Diamond S; Razzaqi F; Ozeran JD; Longhurst M; Andersen EF; Toydemir RM; Hong B
    Genes Chromosomes Cancer; 2019 Aug; 58(8):551-557. PubMed ID: 30706625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute myeloid leukaemia with t(8;21)(q22;q22.3) and loss of the X chromosome.
    Mohamed M; Dun K
    BMJ Case Rep; 2015 Aug; 2015():. PubMed ID: 26250367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor survival in t(8;21) (q22;q22)-associated acute myeloid leukaemia with leukocytosis.
    Billström R; Johansson B; Fioretos T; Garwicz S; Malm C; Zettervall O; Mitelman F
    Eur J Haematol; 1997 Jul; 59(1):47-52. PubMed ID: 9260580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary genetic lesions in acute myeloid leukemia with inv(16) or t(16;16): a study of the German-Austrian AML Study Group (AMLSG).
    Paschka P; Du J; Schlenk RF; Gaidzik VI; Bullinger L; Corbacioglu A; Späth D; Kayser S; Schlegelberger B; Krauter J; Ganser A; Köhne CH; Held G; von Lilienfeld-Toal M; Kirchen H; Rummel M; Götze K; Horst HA; Ringhoffer M; Lübbert M; Wattad M; Salih HR; Kündgen A; Döhner H; Döhner K
    Blood; 2013 Jan; 121(1):170-7. PubMed ID: 23115274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical analysis of acute myeloid leukemia with t(8;21) (q22;q22) and loss of Y chromosome].
    Zhu CY; Yang H; Niu JH; Zhang Q; Xie XL; Wang LJ; Zhu HY; Yao ZL; Yu L; Jing Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):950-6. PubMed ID: 25130809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease features in acute myeloid leukemia with t(8;21)(q22;q22). Influence of age, secondary karyotype abnormalities, CD19 status, and extramedullary leukemia on survival.
    Rege K; Swansbury GJ; Atra AA; Horton C; Min T; Dainton MG; Matutes E; Durosinmi M; Treleaven JG; Powles RL; Catovsky D
    Leuk Lymphoma; 2000 Dec; 40(1-2):67-77. PubMed ID: 11426630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute myeloid leukemia associated with variant t(8;21) detected by conventional cytogenetic and molecular studies: a report of four cases and review of the literature.
    Huang L; Abruzzo LV; Valbuena JR; Medeiros LJ; Lin P
    Am J Clin Pathol; 2006 Feb; 125(2):267-72. PubMed ID: 16393685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemia.
    Balgobind BV; Van den Heuvel-Eibrink MM; De Menezes RX; Reinhardt D; Hollink IH; Arentsen-Peters ST; van Wering ER; Kaspers GJ; Cloos J; de Bont ES; Cayuela JM; Baruchel A; Meyer C; Marschalek R; Trka J; Stary J; Beverloo HB; Pieters R; Zwaan CM; den Boer ML
    Haematologica; 2011 Feb; 96(2):221-30. PubMed ID: 20971820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translocation (3;21;8)(q21;q22;q22) in a patient with acute myeloid leukemia. A case report and review of prognostic indicators.
    Giles FJ; Kanemaki TJ; Schreck RR; Qasabian L; Fuerst MP; Lim SW
    Cancer Genet Cytogenet; 1998 Jul; 104(1):66-9. PubMed ID: 9648562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22).
    Baer MR; Stewart CC; Lawrence D; Arthur DC; Byrd JC; Davey FR; Schiffer CA; Bloomfield CD
    Blood; 1997 Aug; 90(4):1643-8. PubMed ID: 9269784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An analysis of cytogenetic characteristics and prognosis of 189 t (8; 21) acute myeloid leukemia patients].
    Liu XP; Xue YP; Liu SH; Mi YC; Han MZ; Xiao ZJ; Bian SG; Wang JX
    Zhonghua Nei Ke Za Zhi; 2006 Nov; 45(11):918-21. PubMed ID: 17313880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Impact of Additional Cytogenetic Aberrations, cKIT and RAS Mutations, and Treatment Elements in Pediatric t(8;21)-AML: Results From an International Retrospective Study by the International Berlin-Frankfurt-Münster Study Group.
    Klein K; Kaspers G; Harrison CJ; Beverloo HB; Reedijk A; Bongers M; Cloos J; Pession A; Reinhardt D; Zimmerman M; Creutzig U; Dworzak M; Alonzo T; Johnston D; Hirsch B; Zapotocky M; De Moerloose B; Fynn A; Lee V; Taga T; Tawa A; Auvrignon A; Zeller B; Forestier E; Salgado C; Balwierz W; Popa A; Rubnitz J; Raimondi S; Gibson B
    J Clin Oncol; 2015 Dec; 33(36):4247-58. PubMed ID: 26573082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.